Literature DB >> 8479756

Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3.

C Cunningham1, M G Dunlop, A H Wyllie, C C Bird.   

Abstract

Although previous studies of acquired loss of heterozygosity (LOH) in colorectal tumours have suggested that a tumour suppressor gene may lie within the short arm of chromosome 8, its precise localisation remains to be determined. To obtain a more accurate positional map 120 colorectal cancers were examined with eight chromosome 8 polymorphic markers comprising both restriction fragment length polymorphisms and microsatellite polymorphisms based on (CA)n repeats. 91 cases were informative and LOH was detected in 47 (51%). The markers most commonly sited within the lost region mapped to the lipoprotein lipase gene (LPL) at chromosome 8p22. From study of tumours showing break-points within 8p, a common region of deletion was established extending centromerically from LPL to the ankyrin 1 gene (ANK1) which is mapped to 8p21.1-11.2. This overlaps with common deleted regions observed in other studies of colorectal tumours (8p23.1-p21.3) and bladder tumours (8p21-q11.2). Taken together, the results in colorectal cancer delineate a region in 8p22-p21.3 where the putative tumour suppressor gene must lie. The chromosome 8p deletions appear to be independent of those involving 5q and 17p in the same tumours. No relationship was found between the presence of 8p deletion and site or stage of the tumour, or the sex or age of the patient at diagnosis.

Entities:  

Mesh:

Year:  1993        PMID: 8479756

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22.

Authors:  Z H Arbieva; K Banerjee; S Y Kim; S L Edassery; V S Maniatis; S K Horrigan; C A Westbrook
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

2.  Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23.

Authors:  J Xu; S L Zheng; G A Hawkins; D A Faith; B Kelly; S D Isaacs; K E Wiley; B Chang ; C M Ewing; P Bujnovszky; J D Carpten; E R Bleecker; P C Walsh; J M Trent; D A Meyers; W B Isaacs
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

3.  N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions.

Authors:  A L Hubbard; D J Harrison; C Moyes; A H Wyllie; C Cunningham; E Mannion; C A Smith
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

4.  Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.

Authors:  B I Sigbjörnsdottir; G Ragnarsson; B A Agnarsson; C Huiping; R B Barkardottir; V Egilsson; S Ingvarsson
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

Review 5.  What we could do now: molecular pathology of colorectal cancer.

Authors:  R S Houlston
Journal:  Mol Pathol       Date:  2001-08

6.  Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma.

Authors:  Suhail K Mithani; Ian M Smith; Joseph A Califano
Journal:  Melanoma Res       Date:  2011-08       Impact factor: 3.599

7.  Deletion mapping of chromosome 8p in colorectal carcinoma and dysplasia arising in ulcerative colitis, prostatic carcinoma, and malignant fibrous histiocytomas.

Authors:  M Chang; K Tsuchiya; R H Batchelor; P S Rabinovitch; B G Kulander; R C Haggitt; G C Burmer
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

8.  Hereditary nonpolyposis colon cancer: analysis of linkage to 2p15-16 places the COCA1 locus telomeric to D2S123 and reveals genetic heterogeneity in seven Canadian families.

Authors:  R C Green; S A Narod; J Morasse; T L Young; J Cox; G W Fitzgerald; P Tonin; O Ginsburg; S Miller; S Jothy
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

9.  Allelic imbalance of 8p indicates poor survival in gastric cancer.

Authors:  Amy J French; Gina Petroni; Stephen N Thibideau; Mark Smolkin; Eric Bissonette; Franco Roviello; Jeffrey C Harper; Benjamin R Koch; Sarah A Anderson; Scott J Hebbring; Steven M Powell
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

10.  Evaluation of loss of heterozygosity and microsatellite instability in human pterygium: clinical correlations.

Authors:  E T Detorakis; G Sourvinos; J Tsamparlakis; D A Spandidos
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.